Integrated DNA Technologies has launched its rhAmpSeq CRISPR Analysis System, an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.
The system uses proprietary IDT rhAmpSeq technology, which enables highly accurate amplicon sequencing on Illumina next-generation sequencing platforms. The rhAmpSeq CRISPR Analysis System consists of design and synthesis of a custom rhAmpSeq CRISPR Panel, an efficient library kit, and access to data analysis through a user-friendly interface. Starting from sample, it can provide results in less than a week, IDT said.
It also includes IDT's rhAmpSeq CRISPR Analysis Tool, a cloud-based data analysis pipeline that produces publication-ready graphs and figures. This comprehensive analysis tool is hosted by BlueBee, an Illumina company.